Epidermolysis Bullosa: New Therapies Target Genetics and Wound Healing
Summary: This Medscape clinical review discusses the latest therapeutic developments for epidermolysis bullosa (EB), a group of rare inherited disorders causing fragile skin and chronic wounds. It covers new gene-targeted therapies, protein replacement approaches, and specialized wound management techniques designed to reduce blistering, improve healing, and enhance quality of life.
Key Highlights:
- Overview of different EB subtypes and genetic causes
- Emerging gene therapy and cell-based treatments
- Advanced wound care strategies tailored to EB
- Focus on reducing scarring, infection, and complications
Keywords: epidermolysis bullosa, genetic wound disorders, EB wound care